Timeline — 1950-1979

59 Entries

The Salk and Sabin polio vaccines, the Cutter Incident, global smallpox eradication, and the dawn of modern vaccine regulation

Try: polio, Salk, Sabin, smallpox, measles, rubella, Cutter

Showing 59 of 59 entries

1950

Hilary Koprowski Administers First Oral Polio Vaccine to Child

Discovery & Development

Koprowski administered his live attenuated oral polio vaccine to a child, predating both Salk's IPV and Sabin's OPV. His vaccine was tested in Africa and Eastern Europe but was not adopted in the U.

1951

Nobel Prize: Max Theiler

Nobel Prize

Awarded for yellow fever vaccine development.

1952

Jonas Salk Develops IPV

Discovery & Development

Salk developed inactivated poliovirus vaccine at University of Pittsburgh.

1952

Polio Epidemic Peak in United States

Public Health Campaign

U. S.

1953

First Japanese Encephalitis Vaccine in Clinical Use

Discovery & Development

Inactivated mouse brain-derived JE vaccine entered routine use in Japan, becoming part of the national immunization program. Later replaced by cell culture-based vaccines due to safety concerns.

1954

Nobel Prize: Enders/Weller/Robbins

Nobel Prize

Awarded for growing poliovirus in cell culture.

1954

First Japanese Encephalitis Vaccine

Discovery & Development

Mouse-brain-derived JE vaccine.

1954

Salk Vaccine Field Trial

Public Health Campaign

Largest medical experiment in history: 1. 8 million Polio Pioneers participated.

1955

Thomas Francis Jr. Announces Salk Trial Results

Key Figure

At the University of Michigan, Francis announced the results of the largest medical field trial in history: the Salk polio vaccine was safe, effective, and potent. The announcement was broadcast nationally.

1955

Salk Vaccine Licensed

Regulatory Milestone

April 12, 1955: Vaccine declared safe, potent, and effective. Licensed same day.

1955-1963

SV40 Contamination

Safety Event

10-30% of IPV contaminated. Approximately 98 million exposed.

1955-present

OPV/VAPP/cVDPV

Safety Event

Live OPV can revert to virulent form.

1955

The Cutter Incident

Safety Event

Live virus in vaccine. 40,000 infected; 56-164 paralyzed; 5-10 deaths.

1955

Gruenberg Committee Reorganizes Vaccine Safety After Cutter

Regulatory Milestone

Following the Cutter Incident, HEW established a technical committee that overhauled the federal framework for vaccine safety testing, manufacturing standards, and lot release protocols.

1956

Albert Sabin OPV Trials in USSR

Key Figure

Unable to conduct large-scale trials in the U. S.

1957

Asian Flu Pandemic Vaccine Development

Public Health Campaign

Hilleman identified the Asian flu virus strain, arranged rapid vaccine production, and helped manufacture 40 million doses before the pandemic wave hit the U. S.

1957

First Adenovirus Vaccine

Discovery & Development

Military vaccine for adenovirus types 4 and 7.

1957

Interferon Discovered (Vaccine-Relevant Immunology)

Scientific Breakthrough

Isaacs and Lindenmann discovered interferon, a protein produced by cells in response to virus infection. Understanding of interferon pathways later informed vaccine adjuvant design and mRNA vaccine safety.

1958

D.A. Henderson Joins Smallpox Eradication Effort

Key Figure

Henderson led the WHO Intensified Smallpox Eradication Programme from 1966-1977, overseeing the surveillance-containment strategy that achieved global eradication.

1960

Hayflick Develops WI-38 Cell Line

Scientific Breakthrough

Human diploid cell line WI-38 developed. Safer alternative to monkey kidney cells.

1960

Nobel Prize: Burnet and Medawar (Acquired Immune Tolerance)

Nobel Prize

Awarded for discovery of acquired immunological tolerance, explaining how the immune system distinguishes self from non-self. Burnet's clonal selection theory became fundamental to vaccinology.

1960s-2000s

Maurice Hilleman's Vaccine Legacy

Key Figure

Hilleman developed over 40 vaccines, including those for measles, mumps, hepatitis A, hepatitis B, chickenpox, meningitis, and pneumonia. Credited with saving more lives than any other scientist in the 20th century.

1961

Stanley Plotkin Develops Rubella Vaccine

Key Figure

Plotkin developed the RA 27/3 rubella vaccine strain using WI-38 human diploid cells. This strain became the global standard and remains in use in the MMR vaccine today.

1961

Sabin Oral Polio Vaccine Licensed (U.S.)

Discovery & Development

Live attenuated OPV. Tested in USSR and Latin America before U.

1962

Oral Polio Vaccine Replaces Salk Vaccine in U.S.

Regulatory Milestone

The U. S.

1963

Measles Vaccination Begins in the United States

Public Health Campaign

Following licensure of the first measles vaccine, mass childhood vaccination campaigns began. Prior to vaccination, measles infected 3-4 million Americans annually with 400-500 deaths.

1963

First Measles Vaccine

Discovery & Development

Both inactivated (Pfizer) and live attenuated (Merck) measles vaccines licensed.

1964

ACIP Established by U.S. Surgeon General

Regulatory Milestone

The Advisory Committee on Immunization Practices was established to provide expert guidance on vaccine use to the CDC. ACIP recommendations become official federal policy once adopted by the CDC director.

1966

Maurice Hilleman's Contributions Begin

Key Figure

Hilleman would develop over 40 vaccines in his career, more than any other scientist. Vaccines include measles, mumps, hepatitis A, hepatitis B, chickenpox, meningitis, pneumonia.

1966

ACIP Issues First Vaccine Recommendations

Regulatory Milestone

ACIP published its first formal vaccination recommendations, covering DTP primary series beginning at 2-3 months of age with boosters at 1 year and pre-school entry.

1967

First Mumps Vaccine

Discovery & Development

Hilleman developed vaccine from his daughter Jeryl Lynn's mumps virus. Jeryl Lynn strain still used in MMR today.

1967

WHO Intensified Smallpox Eradication Programme

International Program

WHO launched global campaign to eradicate smallpox.

1968

Hong Kong Flu Pandemic Vaccine Response

Public Health Campaign

Rapid vaccine development during the 1968 H3N2 pandemic, with vaccines available within months. An estimated 1 million people died worldwide despite vaccination efforts.

1969

Nobel Prize: Delbruck, Hershey, and Luria (Virus Replication)

Nobel Prize

Awarded for discoveries concerning the replication mechanism and genetic structure of viruses. Their phage group research laid the foundation for molecular virology and modern vaccine design.

1970

Reyes v. Wyeth Laboratories

Legal & Legislative

Federal court held Wyeth liable for polio caused by its oral polio vaccine in an 8-month-old child, establishing duty to warn of vaccine risks when administered without physician intermediary.

1970

First Rubella Vaccine

Discovery & Development

Plotkin developed RA 27/3 rubella vaccine strain still in use today.

1971

MMR Combined Vaccine Licensed

Discovery & Development

Measles, mumps, rubella combined into single injection.

1971

MMR Combination Approved

Regulatory Milestone

FDA licensed the combined measles, mumps, and rubella (MMR) vaccine developed by Hilleman at Merck, reducing three separate injections to one.

1972

Smallpox Vaccine Removed from U.S. Schedule

Regulatory Milestone

Routine smallpox vaccination discontinued in the United States as the disease neared global eradication. The decision reflected that vaccine risks had come to exceed disease risks domestically.

1972

Nobel Prize: Edelman and Porter (Antibody Structure)

Nobel Prize

Awarded for determining the chemical structure of antibodies. Understanding antibody architecture enabled rational vaccine design and monoclonal antibody development.

1972

Biologics Oversight Transferred to FDA

Regulatory Milestone

Regulatory oversight of biological products, including vaccines, was transferred from the NIH Division of Biologics Standards to the FDA, consolidating all drug and biologic regulation under one agency.

1974

India Smallpox Eradication Campaign Intensifies

Public Health Campaign

India launched a massive search-and-contain strategy for smallpox, deploying hundreds of thousands of health workers. India reported its last smallpox case in May 1975.

1974

WHO Expanded Programme on Immunization (EPI)

International Program

EPI established to ensure all children worldwide access to vaccines. Target: DTP, polio, measles, BCG, tetanus toxoid.

1974

WHO EPI Formalizes Cold Chain Requirements

Vaccine Platform / Technology

WHO and UNICEF developed the cold chain -- an integrated system of refrigerated storage and transport from manufacturer to point of use -- essential for delivering vaccines in tropical climates.

1974-1975

Japan DTP Suspension

Safety Event

Two infant deaths led to suspension. 1979 epidemic followed.

1975

Last Case of Variola Major (Rahima Banu, Bangladesh)

Disease Eradication

Three-year-old Rahima Banu on Bhola Island, Bangladesh, was the last person to contract naturally occurring variola major, the more severe form of smallpox with approximately 30% case fatality rate. Detected October 16, 1975.

1975-1981

Japan Develops Acellular Pertussis Vaccine (DTaP)

Discovery & Development

Following Japan's 1974-75 DTP suspension, Japanese researchers began developing acellular pertussis vaccines with fewer side effects. Japan adopted DTaP in 1981, decades before Western countries.

1976

National Swine Flu Immunization Program

Public Health Campaign

President Ford ordered mass vaccination against a feared swine flu pandemic. Over 40 million Americans were vaccinated before the program was halted due to GBS cases and the expected pandemic never materialized.

1976

Nobel Prize: Baruch Blumberg (Hepatitis B Antigen)

Nobel Prize

Awarded for discovery of the hepatitis B surface antigen and development of diagnostic tests, which directly enabled creation of the hepatitis B vaccine.

1976

Swine Flu Vaccine / GBS

Safety Event

43 million vaccinated. Approximately 450 GBS cases.

1977

Last Natural Smallpox Case

Disease Eradication

Ali Maow Maalin: last known natural case of smallpox (variola minor).

1977

Last Case of Variola Major Worldwide

Disease Eradication

The last naturally occurring case of variola major (the more severe form of smallpox) was recorded in Bangladesh in October 1975. The last case of variola minor followed in Somalia in 1977.

1977

First Pneumococcal Vaccine

Discovery & Development

14-valent pneumococcal polysaccharide vaccine.

1977

Smallpox Eradication: Ring Vaccination Strategy

Public Health Campaign

The surveillance-containment or ring vaccination strategy -- vaccinating contacts and contacts-of-contacts around each case rather than attempting mass vaccination -- proved decisive in the final eradication push.

1978

First Meningococcal Vaccine

Discovery & Development

Polysaccharide vaccine for Neisseria meningitidis.

1978

National GBS Surveillance Launched

Safety Event

CDC/AAN/CSTE surveillance in response to 1976.

1978

Expanded Programme on Immunization Reaches 5% Global Coverage

International Program

Four years after launch, the WHO EPI had reached only about 5% of children in developing countries. Massive scale-up efforts over the following decade raised coverage to approximately 80% by 1990.

1979

Janet Parker: Last Smallpox Death

Safety Event

Medical photographer Janet Parker died of smallpox contracted from a laboratory at the University of Birmingham. Her death prompted global review of biosafety protocols for dangerous pathogens.

1979

Last Natural Smallpox Case Confirmed (Ali Maow Maalin)

Disease Eradication

Somali hospital cook Ali Maow Maalin was identified as the last person to contract naturally occurring smallpox (variola minor) on October 26, 1977. Final confirmation and surveillance completed by 1979.

Report Inaccuracy
Back to Top